pre-print 28 November 2021 Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response * Human common cold CoV (hCCCoV) antibodies before and after SARS-CoV-2 infection was assessed * Betacoronavirus hCCCoV antibodies are boosted after SARS-CoV-2 infection * Baseline hCCCoV antibodies do
pre-print 29 April 2020 Far-UVC light safely inactivates Coronaviruses A paper in review at Nature Research [https://www.researchsquare.com/article/rs-25728/v1] demonstrates that far-UVC light (207-222 nm) efficiently kills pathogens, including coronaviruses
pre-print 24 April 2020 Pharmacology of Chloroquine + Azirthromycin in Mx of COVID-19 A pre-print paper [https://www.mediterranee-infection.com/wp-content/uploads/2020/04/azithroquine_manuscript-soumis.pdf] summarised the pharmacology of Hydroxychloroquine and azithromycin as early treatment options
pre-print 14 April 2020 Cloth masks reduce transmissibility of SARS-CoV-2 A pre-print evidence review paper (non-peer-reviewed) entitled, 'Face Masks Against COVID-19: An Evidence Review [https://www.preprints.org/manuscript/202004.0203/v1]' recommends the
pre-print 12 April 2020 Chloroquine with Azithromycin may have synergistic effects on QT length, needs caution A pre-print paper (medrxiv) suggests that while, 'short-term hydroxychloroquine treatment is safe, addition of azithromycin may induce heart failure and cardiovascular mortality, potentially due to
pre-print 12 April 2020 ACE-inhibitors associated with lower COVID-19 severity Contrary to the initial hypothesis that ACE-inhibitors may increase the risk of severe COVID-19 infection, a small study with a cohort of 205 acute COVID-19
